23.04.2010 • News

Eastman Revenue Soars, Considers Divestiture of PET Business

Eastman Chemical reported a first-quarter profit that soared as sales jumped in all five of its operating units. For the period, the company said net income was $101 million, or $1.37 per share, compared with $2 million, or 3 cents per share, in the year-ago period.

Analysts expected earnings of $1.15 per share, according to Thomson Reuters I/B/E/S. Revenue at the Kingsport, Tennessee-company rose 38.5% to $1.56 billion. Analysts expected $1.29 billion in revenue. The company had warned in March that a recent shutdown at a Texas plant would cut first-quarter earnings by at least 20 cents per share.

For the second quarter, Eastman expects to earn $1.50 to $1.60 per share. Analysts expect $1.19 per share. For the year, the company expects to earn $5 to $5.25 per share. Analysts expect $4.51 per share. "With volumes recovering and product mix improving, our first-quarter earnings demonstrated the strength of our core businesses," Chief Executive Jim Rogers said in a statement.

Despite the positive financials Eastman announced it will review strategic options, including a possible divestiture, for its PET business in the Performance Polymers segment. The company has retained Bank of America Merrill Lynch as its exclusive financial advisor for the strategic review.

Company

Eastman Chemical Company

200 South Wilcox Drive
37662 Kingsport

Company contact







Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read